Literature DB >> 1295359

Antigen-induced hyperresponsiveness to methacholine in ventilated, anesthetized guinea pigs.

M L Burgess1, B J Everitt.   

Abstract

Guinea pigs were actively sensitized to ovalbumin and exposed 2-3 weeks later to an aerosol of ovalbumin or saline. Changes in lung function were assessed 0.5, 1, 6, 24 and 72 h later by measuring the peak increase in pulmonary inflation pressure induced by i.v. methacholine during constant-volume ventilation. Responses to methacholine were significantly potentiated at 0.5, 1, 6 and 24 h but not at 72 h following exposure to antigen. Hyperresponsiveness to methacholine was maximal at 0.5-1 h and, in terms of magnitude, comparable to the early increase in airway reactivity found in mild asthmatics after allergen challenge. Whether the hyperresponsiveness to methacholine induced by antigen in the guinea pig can be attributed solely to an increase in airway reactivity or is due, at least in part, to decreased lung compliance requires further study.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1295359     DOI: 10.1007/bf02028097

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  4 in total

1.  Bronchial reactivity increases soon after the immediate response in dual-responding asthmatic subjects.

Authors:  J E Thorpe; D Steinberg; I L Bernstein; C G Murlas
Journal:  Chest       Date:  1987-01       Impact factor: 9.410

2.  The effect of the selective PAF antagonist BN 52021 on PAF- and antigen-induced bronchial hyper-reactivity and eosinophil accumulation.

Authors:  A J Coyle; S C Urwin; C P Page; C Touvay; B Villain; P Braquet
Journal:  Eur J Pharmacol       Date:  1988-03-22       Impact factor: 4.432

3.  Allergen-induced increase in non-allergic bronchial reactivity.

Authors:  D W Cockcroft; R E Ruffin; J Dolovich; F E Hargreave
Journal:  Clin Allergy       Date:  1977-11

4.  Airway hyperreactivity follows anaphylactic microshock in anaesthetized guinea-pigs.

Authors:  L Daffonchio; A N Payne; I W Lees; B J Whittle
Journal:  Eur J Pharmacol       Date:  1989-02-28       Impact factor: 4.432

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.